Oncology
Teclistamab in a Large Cohort of ~100 Asian Patients with Triple-Class Exposed Multiple Myeloma: Experience from Trial and Non-Trial Settings
Connect with us
Connect with us
Would you like to clear and leave your conversation? Message history will be lost.